Dankang BioHealth
Retatrutide
Finnrick tested 16 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Dankang BioHealth between 1 Jan 2026 and 6 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Dankang BioHealth
Retatrutide
Tested 16 Samples
Last test 6 Mar 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Dankang BioHealth
Samples are tested in commercial labs
Tests Count
16
Scores
AVGMINMAX
Last
6 Mar 2026
First
1 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 6 Mar 2026 | View | 10mg | 9.47mg | -5.3% | 99.90% | n/a | Nov2, 2025 | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 6 Mar 2026 | View | 30mg | 29.5mg | -1.7% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 4 Mar 2026 | View | 20mg | 18.8mg | -6.0% | 99.80% | n/a | 2025/10/22 | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 3 Mar 2026 | View | 10mg | 10.7mg | +7.0% | 97.80% | n/a | 2025/10/22 | Black Label / Silver Crimp / Green Cap | Lab E | Public | |
| 2 Mar 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | 12/23/25 | No Label / Silver Crimp / White Cap | Lab E | Public | |||
| 1 Mar 2026 | View | 10mg | 14.5mg | +45.0% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 22 Feb 2026 | View | 20mg | 20.1mg | +0.5% | 99.90% | below LOQ | 2025/12/25 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 20 Feb 2026 | View | 10mg | 12.8mg | +28.0% | 99.90% | n/a | (no batch ID) | (no data) | Lab E | Public | |
| 18 Feb 2026 | View | 30mg | 28.7mg | -4.3% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 13 Feb 2026 | View | 15mg | 15.2mg | +1.3% | 99.90% | below LOQ | 2025/12/25 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 11 Feb 2026 | View | 50mg | 52.4mg | +4.8% | 99.90% | n/a | 12/25/25 | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 22 Jan 2026 | View | 20mg | 25.2mg | +26.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 19 Jan 2026 | View | 30mg | 29.4mg | -2.0% | 99.95% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 15 Jan 2026 | View | 20mg | 20.6mg | +3.0% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 7 Jan 2026 | View | 10mg | 10.4mg | +4.0% | 99.70% | n/a | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |
| 1 Jan 2026 | View | 5mg | 4.4mg | -12.0% | 99.60% | n/a | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab G | Public | |